Life Sciences

Pharmaceutical companies should make grant process transparent

Pharma Compliance Alert, February 4, 2009

In theory, creating a grant strategy is easy, but not in practice, said Belinda Hunt, PhD, associate director of medical education and grants at Biogen Idec in Wellesley, MA.

Hunt, speaking on a panel during the Center for Business Intelligence’s Sixth Annual Pharmaceutical Compliance Congress in Washington D.C. January 27, said companies should first set up a grant committee to evaluate each grant application. The authority to approve grants can reside in the medical affairs, legal, or compliance department, but should not be in the sales and marketing department.

Continue reading for more about the grant process.

Comments

0 comments on “Pharmaceutical companies should make grant process transparent

 

Most Popular